SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001367644-08-000021
Filing Date
2008-04-15
Accepted
2008-04-15 16:22:00
Documents
6
Period of Report
2008-04-15
Effectiveness Date
2008-04-15

Document Format Files

Seq Description Document Type Size
1 def14a-final_proxy.htm DEF 14A 566832
3 GRAPHIC img1.jpg GRAPHIC 4615
4 GRAPHIC ballot.jpg GRAPHIC 751
5 GRAPHIC ballotx.jpg GRAPHIC 762
6 GRAPHIC cardimage.jpg GRAPHIC 92621
7 GRAPHIC cardimage1.jpg GRAPHIC 128344
  Complete submission text file 0001367644-08-000021.txt   881854
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33137 | Film No.: 08757412
SIC: 2834 Pharmaceutical Preparations